Enzyme, Kinase, Serine/threonine-protein kinase, AGC kinase family, Rho/Rac effector, Protein kinase N (PKN) family
01
Overview
Protein kinase N2 (PKN2) is a serine/threonine-protein kinase and a member of the protein kinase N (PKN) family, encoded by the PKN2 gene. It acts as a downstream effector for Rho/Rac GTPases, regulating processes such as cell cycle progression, actin cytoskeleton organization, cell adhesion, migration, and transcriptional activation. PKN2 is essential for proper cell division and differentiation, participates in signaling pathways controlling apoptosis and cell motility, and plays a pivotal role in glucose and lipid metabolism, particularly by modulating insulin responsiveness in skeletal muscle. It has been implicated in cancer cell invasion and migration, certain developmental syndromes, and viral infections such as hepatitis C virus, and is considered a relevant therapeutic target for diverse biological and pathological processes.
Most small-molecule inhibitors act as ATP-competitive kinase inhibitors, inhibiting the kinase activity of PKN2, thereby modulating downstream cell signaling. Inhibitors of PKN2 affect processes such as tumor invasion and cell migration via interference with phosphorylation events.
03
Biological functions
Cell cycle progression regulationPositive regulation of mitotic cell cycleActin cytoskeleton assemblyCell migrationCell adhesionTumor cell invasionTranscription activationProtein phosphorylationRegulation of glucose and lipid metabolismSignal transductionRegulation of cytokinesisApoptotic process
04
Disease associations
Cancer (tumor cell invasion, migration, adhesion)Metabolic disorders (regulation of insulin signaling, impact in type 2 diabetes, glucose and lipid homeostasis)Developmental disorders (associated with syndromes such as toe syndactyly, telecanthus, anogenital and renal malformations)Infection (direct role in viral genome replication; interaction with hepatitis C virus (HCV))Other (general roles due to broad impact on cell signaling and apoptosis)
05
Safety considerations
Embryonic lethality in knockout mice indicates PKN2 is essential for development, suggesting potential safety challenges if targeted systemicallyBroad physiological roles mean inhibition may affect normal cell cycle and cytoskeletal dynamics, raising concerns for off-target effects and toxicity
06
Interacting drugs
Multiple kinase inhibitors (specific small-molecule inhibitors of serine/threonine kinases are active at PKN2, but no uniquely PKN2-selective, clinically approved agent as of the search; PKN2 is included in kinase inhibitor screens such as DiscoveRx KINOMEscan and EMD Millipore KinaseProfiler)
2 more in the full profile.
07
Biomarkers
PKN2 expression/activity may serve as a biomarker for:Cell cycle regulation statusTumor cell invasivenessInsulin responsiveness in skeletal muscle (explored in type 2 diabetes research)
Beyond the preview
Go deeper on Protein kinase N2 (PKN2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Protein kinase N2 (PKN2).